相关实验视频

Updated: May 29, 2025

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

慢性鼻炎的个性化医学:可治疗的特征使用生物药物满足未满足需求

Mitsuhiro Okano¹, Marie Yamada², Aiko Oka²

¹Department of Otorhinolaryngology, International University of Health and Welfare School of Medicine, Narita, Japan. mokano@iuhw.ac.jp.

Allergy, asthma & immunology research

|February 3, 2025

概括

慢性鼻炎 (CRS) 是一种复杂的呼吸道疾病,具有不同类型的炎症. 个性化的"可治疗特征"治疗,包括2型炎症的生物药物,改善了结果,但需要进一步细化.

科学领域:

免疫学免疫学免疫学
耳鼻喉科耳鼻喉科耳鼻喉科
肺部病理学肺部病理学

背景情况:

慢性鼻炎 (CRS) 是一种广泛的疾病,对健康和经济产生重大影响,其特点是多种炎症途径.
慢性神经系统病变异质,导致治疗反应和预后的变化,需要个性化管理策略.
基于细胞因子配置的炎症内型 (类型1,2,3) 对于理解CRS异质性至关重要,而eosinophilia是2型CRS的关键生物标志物.

研究的目的:

审查慢性鼻炎 (CRS) 的不断发展的治疗策略,重点关注转向基于内型的管理.
突出2型炎症及其相关生物标志物和针对性生物疗法在CRS中的作用.
讨论CRS个性化治疗方法的改进方面的挑战和未来方向.

主要方法:

慢性鼻炎 (CRS) 病原,内型和治疗演变的文献综述.
分析了eosinophilia作为2型CRS生物标志物的作用.
检查当前和新兴的生物疗法,针对CRS中的特定炎症途径.

主要成果:

东亚的CRS患病率显示了转向2型埃索诺菲尔炎症的转变.
针对IL-4/IL-13R,IL-5和TSLP的生物药物对2型CRS特征有效,改善了患者的治疗结果.
挑战包括管理高氨酸和优化生物选择和测序.

结论:

这是一个很棒的节目,这是一个很棒的节目.

关键词:

鼻炎是指鼻炎的一种疾病.生物产品是生物产品.埃索诺菲尔细胞的存在互乐金-13是什么意思介质蛋白-4 介质蛋白-4 互白素-5-5的作用是什么中性粒细胞中性粒细胞.现象型现象型是一种现象型.精准医学是一门精准医学.

更多相关视频

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

Primary Human Nasal Epithelial Cells: Biobanking in the Context of Precision Medicine

Primary Human Nasal Epithelial Cells: Biobanking in the Context of Precision Medicine

Published on: April 22, 2022

相关概念视频

Drugs Used in Lower Respiratory Disorders: Overview

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

Drugs Used in Upper Respiratory Disorders: Overview

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

Drug Delivery: Miscellaneous Routes

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...

Inhaled Medications

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...